Ascendis Pharma A/S vs Occidental Petroleum Corporation — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Occidental Petroleum Corporation trades at $58.79 (market cap $55.89B). The key difference: Occidental Petroleum Corporation is far larger — about 3.4× Ascendis Pharma A/S's market cap, and Occidental Petroleum Corporation pays a 2% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | OXY | |
|---|---|---|
Market Cap | $16.67B | $55.89B |
Sector | Health | Energy |
52-Week High | $277.18 | $66.24 |
52-Week Low | $189.74 | $38.92 |
Enterprise Value | $17.04B | $74.65B |
Dividend Yield | — | 2% |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →